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ABO and Rh(D) blood typing is one of the most important tests performed prior to blood transfusion.
Although on-site blood testing is desirable for expedient blood transfusion procedure, most conventional
methods and instruments lack the required usability or portability. Here, we describe a novel method,
based on the detection of hemagglutination using an optical waveguide-mode sensor, for on-site use.
The reﬂectance spectrum of blood alone and that of blood mixed with antibody reagents was measured
using the waveguide-mode sensor. Differences in reﬂectance by agglutinated and non-agglutinated blood
samples were observed at the bottom of the spectral dips; due to differences in the manner in which red
blood cells interacted with the surface of the sensor chip. Following the addition of the antibody, blood
types A, B, O, and AB were clearly distinguishable and Rh(D) typing was also possible using the wave-
guide-mode sensor. Furthermore, the waveguide-mode-based measurement exhibited the potential to
detect weak agglutination, which is difﬁcult for human eyes to distinguish. Thus, this method holds great
promise for application in novel on-site test instruments.
 2014 The Authors. Published by Elsevier B.V. This is an open access articleunder the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Blood type, represented by the ABO and Rh(D) systems, is an
immunoreactive feature of red blood cells (RBCs) that is deter-
mined by the antigenic moieties of sugar chains on the RBC surface.
Determination of the blood type is especially important before
blood transfusion, because transfusion of mismatched blood types
can lead to hemolysis within patient’s blood vessels, which medi-
ated by antibodies to the RBCs in blood plasma. Blood typing tests
have traditionally been conducted manually, using techniques
such as slide and tube agglutination tests. In the last 20–30 years,
fully automated blood testing instruments have been developed
and these are operational at blood centers and major hospitals.
These instruments have advantages such as high throughput and
high sensitivity. However, these advantages are somewhat offsetby the large size and high cost of the instruments. These are major
drawbacks, especially because on-site blood testing is an
important requirement during an emergency or natural calamity.
Development of a portable, low-cost, and sufﬁciently sensitive
instrument for blood typing is therefore required to make on-site
blood testing feasible.
Agglutination of RBCs (hemagglutination) is caused by an
immune reaction between the RBCs and antibodies against the cor-
responding blood type. In conventional blood typing methods,
hemagglutination caused by antibodies is detected by human eyes
or by imaging techniques. Alternate methods of blood typing using
optical techniques have also been reported. Quinn et al. ﬁrst
reported the use of a surface plasmon resonance (SPR) sensor for
blood typing [1]. The SPR sensor is a sensitive biosensing instru-
ment based on electrical ﬁeld enhancement by SPR excitation [2–
4]. SPR-based blood typing has been previously performed using
the Biacore system [1,5,6] or an SPR imaging technique [7]. Naraya-
nan et al. have reported a technique for absorbance measurement-
based blood typing [8]. This group reported the detection of a weak
agglutination reaction of A2 subtype and weak-D. Robb et al. dem-
onstrated ﬂuorescence-based blood typing on a planar microarray
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formed using a microchannel [9–11] or paper [12,13].
In this study, we propose a blood typing method using an opti-
cal waveguide-mode sensor that detects changes in absorbance
properties of the blood sample. The waveguide-mode sensor uti-
lizes electric ﬁeld enhancement in the sensor chip, similar to the
SPR sensor, and is, therefore, more sensitive than a reﬂectance
absorption spectrometer. The waveguide-mode sensor-based
method provides a simple and sensitive blood typing technique,
and utilizes a portable, small-sized instrument. Hemagglutination
detection using the waveguide-mode sensor in this study was
examined both theoretically and experimentally, using human
blood and blood typing antibody reagents. ABO and Rh(D) blood
typing was conducted using the waveguide-mode sensor-based
hemagglutination detection method.RBC + plasma surface RBC surface 
Fig. 1. (a) A schematic diagram of the experimental setup to detect hemaggluti-
nation. a represents base angle of the trapezoidal prism. (b) Schematic diagrams of
the sensor chip surface with blood samples containing (i) non-agglutinated and (ii)
agglutinated RBCs. Red circles represent individual RBCs.2. Materials and methods
2.1. Materials
Reagents were used as received with no further puriﬁcation.
Human whole blood containing the anticoagulant ethylenedi-
aminetetraacetic acid dipotassium salt (EDTA 2K) was purchased
from Tennessee Blood Service. Tubes containing fresh blood
samples were shipped by air and used within 2 weeks. Before
using the sample, we checked for hemolysis and used only non-
hemolyzed samples. Blood types were conﬁrmed by the supplier.
Monoclonal anti-A and anti-B reagents (Neo Kokusai) were pur-
chased from Sysmex Corporation. Monoclonal anti-D reagent
(Monoclonal Anti-D Wako), Rh control reagent, and phosphate-
buffered saline (PBS) was purchased from Wako Pure Chemical
Industries, Ltd. Refractive index matching liquid for fused silica
(Fused Silica Matching Liquids 50350) was purchased from Cargille
Laboratories. Waveguide-mode sensor chips were supplied from
Shin-Etsu Chemical Co., Ltd.2.2. Experimental details
Hemagglutination was detected using a spectral readout-type
waveguide-mode sensor [14]. Fig. 1(a) shows a schematic drawing
of the experimental setup. The waveguide-mode sensor is based on
the Kretschmann conﬁguration containing a white light-emitting
device (LED), collimator lens, polarizer, trapezoidal prism, sensor
chip, and spectrometer. All the components of the waveguide-
mode sensor are enclosed within a 30  20  15 cm3 box, making
the device portable. The sensor chip consists of a surface SiO2 glass
waveguide layer and an embedded silicon reﬂectance layer on sil-
ica glass [15]. The chips are placed on the prism at base angle 38,
which corresponds to an incident angle of 70.6 and the index
matching liquid is introduced in between. S-polarized incident
light from the LED is irradiated onto the chip from the bottom,
and the spectrum of the reﬂected light is measured by the spec-
trometer. Dips in reﬂectance were observed because of excitation
of waveguide-mode propagation. By monitoring alteration in the
dips, changes in the complex refractive index in the vicinity of
the sensor chip surface can be detected. The wavelength of the
spectral dip is controlled by adjusting the thickness of the SiO2
waveguide layer and the silicon reﬂectance layer. In this study,
the thickness of the waveguide layer and reﬂectance layer of the
chips were approximately 360 and 45 nm, respectively. Those
chips exhibited spectral dip around 540 nm during blood measure-
ments, which were calibrated as per the peak wavelength for the
RBC absorbance spectrum. For the hemagglutination detection
measurements, a drop of the blood sample was directly placed
onto the calibrated chip without surface modiﬁcations.Fig. 1(b) shows a schematic diagram of the sensor chip surface
during analysis of blood samples. In case of non-agglutinated blood
samples, RBCs will sediment uniformly and form a dense layer on
the chip surface. By contrast, agglutinated RBCs (e.g., blood A
mixed with anti-A) will sediment discretely onto the chip surface.
Consequently, according to the ratio of contact area of RBCs to the
surface, the complex refractive indices of the chip surface differ
between the agglutinated and non-agglutinated blood samples.
Since RBCs exhibit absorption around 540 nm while plasma does
not, we focused on the change in extinction coefﬁcient due to hem-
agglutination. The spectral response of the waveguide-mode sen-
sor to hemagglutination was calculated using the transfer matrix
method. To represent hemagglutination in the calculation, we
assumed uniformly mixed layers that contained RBCs and plasma
in various ratios. The extinction coefﬁcient k of both RBCs and
plasma, was calculated from the absorbance A as follows:
k ¼ ln 10 Ak
4pd
ð1Þ
where k is the wavelength and d is the optical path length. The
absorbance was measured using NanoDrop 2000c (Thermo Fisher
Scientiﬁc Inc.). The values of k of RBCs and plasma derived using
the measured absorbance and Eq. (1) are shown in Supplementary
Fig. S1. The k value of the mixed layer was derived from the
weighted average k of RBCs and plasma according to the composi-
tion ratio. For the refractive index, n, a previously reported value
for RBCs, n = 1.40, was used [16].
For detection of hemagglutination using the waveguide-mode
sensors, samples of human whole blood were diluted with PBS to
5% of the RBC volume. First, the spectral responses for agglutinated
and non-agglutinated blood samples were examined using the
diluted blood and blood-antibody mixture in a 1:1 ratio by volume.
Second, ABO forward blood typing was conducted using blood
types A, B, O, and AB. Diluted blood was placed onto the sensor
chip surface, antibody reagents were added and mixed gently by
pipetting. The spectra of the blood and blood-antibody mixture
were measured and compared to identify any antibody-dependent
change. Rh(D) blood typing was also performed. All reactions and
measurements were conducted at room temperature.
H. Ashiba et al. / Sensing and Bio-Sensing Research 3 (2015) 59–64 613. Results and discussion
3.1. Hemagglutination detection
The calculated spectral responses of waveguide-mode sensor
measurements of blood samples are shown in Fig. 2. The reﬂec-
tance spectrum for the composition ratio of RBCs from 0% to
100% is presented. In the calculation, S-polarized light was set at
an incident angle of 70.6. Calculation layers were set, from the
bottom to the top, as silica glass, 45-nm single crystalline silicon,
360-nm SiO2 glass, blood sample, and ambient blood plasma. The
blood sample layer consists of a mixture of RBCs and blood plasma
in various ratios. The optical property of the blood sample layer
was set to reﬂect the composition ratio as described in Subsection
2.2. The thickness of the blood sample layer was assumed to be
35 nm, derived as a ﬁtting parameter to reproduce a dip in the cal-
culated reﬂectance spectrum at the wavelength of 540 nm. In other
words, the assumed sample layer thickness was chosen to reﬂect
the contribution of RBCs to the optical response in this model.
Under these conditions, as the proportion of RBCs in the sample
decreased, the reﬂectance at the bottom of the spectral dip (bottom
reﬂectance) increased. This implies that hemagglutination can be
detected by an increase in the bottom reﬂectance. Of note, the cal-
culation relies on the assumption that blood samples form a phys-
ical ‘‘layer’’, although this may not always apply in experimentalFig. 2. Simulated spectral response of a waveguide-mode sensor analyzing blood
samples containing RBCs in various proportions.
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Fig. 3. Reﬂectance spectra of type A blood samples measured using a waveguide-mode
sample are shown in colored, solid lines. Gray dotted and dashed lines represent dip re
agglutinated samples (‘‘Blood A + anti-A’’), respectively. The agglutinated sample elicitsconditions, since the boundary between blood inside the detection
range (several hundred nanometers from the surface of the sensor
chip) and that outside should be ambiguous. The assumed 35-nm
thickness of the blood sample layer was miniscule, as compared
to the thickness of an individual RBC (approximately 2-lm), and
we deduce this was due to the assumption of the ‘‘layer’’. Quanti-
tative discussions using our model would be inadequate. However,
our results are sufﬁcient to derive qualitative information. Clearly,
for a more quantitative method, an advanced calculation model is
desirable.
Fig. 3 shows the spectral responses derived from blood samples
in the waveguide-mode sensor. A 50-lL droplet of plain blood,
blood mixed with anti-A, or blood mixed with anti-B was placed
on the waveguide-mode sensor chips using a micropipette. Since
type A blood was used in this measurement, the blood mixed with
anti-A should agglutinate, whereas that with anti-B did not. In
Fig. 3, the spectrum just after the sample drop (‘‘0 min’’ curves)
was similar in all 3 samples. As time progressed from placing the
sample drop, the dips in the spectrum were deeper because of
the gravitational sedimentation of RBCs onto the chip surface. After
10 min, the dips reached a plateau. In this state, the spectrum of
the non-agglutinated samples (‘‘Blood A’’ and ‘‘Blood A + anti-B’’)
and the agglutinated sample (‘‘Blood A + anti-A’’) were clearly dif-
ferent: the dip of the agglutinated sample elicited higher bottom
reﬂectance than that of the non-agglutinated samples. This trend
is consistent with the calculated result (Fig. 2). Observation of
the samples using an optical microscope (BX51, Olympus Corpora-
tion) supported the hemagglutination state of the samples. Thus,
hemagglutination detection using the waveguide-mode sensors
can be conducted by comparing the bottom reﬂectance of the dip
at or near the plateau. The spectra in Fig. 3 show that measure-
ments made at 5–10 min after placing the drop are appropriate
for the bottom reﬂectance comparison to detect hemagglutination
when the spectral response approaches a plateau. This timeframe
was employed in the tests that followed.3.2. ABO and Rh(D) blood typing
The waveguide-mode sensor-based ABO blood typing test was
conducted using A, B, O, and AB blood types. To observe changes
in the bottom reﬂectance of the dips caused by addition of anti-A
and anti-B antibodies, the spectra of blood and blood-antibody
mixture were serially measured (Fig. 4(a)). Samples used were of
50 lL each. Spectra of blood-only samples were obtained 10 min
after the sample was placed and those of blood-antibody mixture(nm) 
ti-A 
d) 
Blood A + anti-B 
(Non-agglutinated) 
sensor. Spectra measured at 0, 1, 2, 3, 5, 10, and 15 min after placing the drop of
ﬂectance levels of the non-agglutinated (‘‘Blood A’’ and ‘‘Blood A + anti-B’’) and the
a higher dip reﬂectance than the non-agglutinated samples.
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ence in the response to addition of the antibody was observed
for each of the blood types: agglutinated samples increased the
bottom reﬂectance, while non-agglutinated samples produced no
signiﬁcant changes. Differences in values of the bottom reﬂectance
between the spectra of blood and blood-antibody mixture are sum-
marized in Fig. 4(b). Types A, B O, and AB were obviously distin-
guishable in the graph. Compared with types A and B, type AB
blood induced a slightly smaller bottom reﬂectance change. This
is likely due to the number of blood type antigens (sugar chains)
on the RBC surface: the total number of these antigens on RBC is
almost the same, and therefore RBCs of type AB have smaller num-
bers of both, type A and B antigens as compared to type A and B
RBCs that possess only A or only B antigens, respectively. In the
waveguide-mode sensor-based hemagglutination detectionType A 
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Fig. 4. (a) ABO blood typing using a waveguide-mode sensor. After measuring the reﬂec
samples and the spectra of the blood-antibody mixture (solid lines) were measured. Spe
antibody mixture were measured 5 min after addition of antibody. (b) Bottom reﬂectan
Photographs of sensor chips analyzing the blood-antibody mixture. Each photograph comethod, we infer that the intensity of agglutination can be esti-
mated by the magnitude of change of the bottom reﬂectance.
Fig. 4(c) shows photographs of the sensor chips that were used
to analyze blood-antibody mixture. The photographs were taken at
the same time as the spectrum measurements shown in Fig. 4(a).
In some cases, visual judgment of agglutination was difﬁcult;
e.g., the difference between ‘‘Blood B + anti-A’’ (non-agglutinated)
and ‘‘Blood B + anti-B’’ (agglutinated) in Fig. 4(c) is not clearly dis-
cernible. However, even in these cases, the difference in spectra
measured using the waveguide-mode sensors was very clear, as
shown in Fig. 4(a). We therefore consider that waveguide-mode
sensor-based hemagglutination detection is more sensitive and
accurate than a visual test. Weak agglutination reactions, such as a
reaction between weak-A RBC antigen and anti-A, sometimes appear
as false negative during the blood testing. Our hemagglutinationType B 
Type AB 
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tance spectra of blood samples (dashed lines), antibody reagents were added to the
ctra were measured 10 min after the sample drop was placed and that of the blood-
ce change between spectra of blood and blood-antibody mixture shown in (a). (c)
rresponds to the spectra shown in (a). Scale bars in the ﬁgure indicate 10 mm.
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challenging cases.
It should be noted that the anti-A and anti-B reagents used in
this study were colored, in the same manner as general diagnostic
reagents used for manual ABO blood typing. The anti-A reagent
was blue and the anti-B reagent was yellow in color, and these col-
ors could possibly affect the reﬂectance spectra of the blood sam-
ples. We checked the effect of the colors by placing a drop of the
antibody reagents alone on the sensor chip. The difference in the
value of the bottom reﬂectance between the spectra of the anti-A
and anti-B reagents was approximately 2%. The effect of the colors
was small as compared to the spectral change caused by hemag-
glutination as shown in Fig. 4(b). In addition, since the effect of
the colors should be constant if the experimental conditions such
as the sample volume and mixture ratio were the same, the effect
can be removed during the analysis. Thus, the colors do not affect
the blood typing using the waveguide-mode sensor.
Our method is not limited to ABO typing, but also applicable to
another tests that use hemagglutination, such as the Rh(D) blood
typing and ABO reverse typing. The reﬂectance spectra of demon-
strated for Rh(D) blood typing is shown in Fig. 5. The anti-D and Rh
control reagents were mixed with Rh+ and Rh blood in equal vol-
umes and the reﬂectance spectra were measured 5 min after plac-
ing a 50-lL droplet of the samples. Rh+ and Rh blood samples
were distinguished by comparing the bottom reﬂectance of the
respective samples, as done for ABO blood typing. The difference
in bottom reﬂectance of the agglutinated Rh+ sample (approxi-
mately 10%) was smaller than that of the agglutinated samplesRh(D)+ 
Rh(D)- 
Fig. 5. Rh(D) blood typing using a waveguide-mode sensor. Spectra measured at
5 min after placing the drop of sample are shown in red (blood and anti-D reagent
mixture) and black (blood and Rh control reagent mixture) solid lines. Rh(D)+ blood
mixed with anti-D reagent showed agglutination and the other samples did not.
Difference in bottom reﬂectance of the spectra of agglutinated Rh(D)+ sample was
observed similar to that obtained with ABO blood typing.from the ABO typing tests (15–35%). Agglutination produced by
the anti-D reagent is generally weaker than that by anti-A and
anti-B reagents, and the smaller magnitude of difference in reﬂec-
tance is considered to reﬂect the intensity of the agglutination
reaction, as previously mentioned regarding ABO blood typing.
Thus, using adequate samples and reagents, our method can be
used in various tests utilizing hemagglutination.3.3. Tolerance for hematocrit variation
Considering on-site blood typing, the volume ratio of RBCs in
blood (hematocrit) of tested samples is usually unknown, and this
can inﬂuence the results. Thus, the method should account for var-
iable values of hematocrit. To this end, the tolerance of the wave-
guide-mode sensor for hematocrit variations was tested. Type A
and B blood samples were diluted with PBS to 2.5%, 5%, 7.5%, and
10% of RBC volume, and measured using the waveguide-mode sen-
sor. The procedure described in Section 3.2 was followed, except
that spectra of the blood-antibody mixture were measured
10 min after the addition of antibody. The difference in the values
of the bottom reﬂectance between the spectra of blood and that of
blood-antibody mixture are shown in Fig. 6. Clear differences
between agglutinated and non-agglutinated samples were
observed for the values of the proportion of RBCs ranging from
5% to 10%. This shows that if a 6-fold dilution of the blood sample
is used, samples that contain between 30% and 60% proportion of
RBCs in the sample volume can be effectively tested. This range
covers the variation in hematocrit of healthy individuals, which
is between 35% and 55%. Thus, the waveguide-mode sensor-based
blood typing test is sufﬁciently tolerant for on-site use. The sam-
ples of 2.5% proportion of RBCs showed relatively shallow dips of
spectra (i.e., the bottom reﬂectance of the dips was high) compared
with those containing a larger proportion of RBCs. We infer that
this is since RBCs would cover the entire surface of the sensor chip
if present at proportions above 5% of the total volume, while RBCs
that constitute less than 2.5% would not. The threshold proportion
of RBCs for adequate coverage of the chip surface is related to the
sample volume per unit area (equal to average height), since the
total number of RBCs sinking onto a unit area of the chip surface
is a product of the blood volume and the proportion of RBCs. We
used 50-lL samples with a diameter of approximately 10 mm in
this study. When using samples of different volumes, theType A 
Type B 
Proportion of RBCs 
Fig. 6. Bottom reﬂectance changes between spectra of blood and blood-antibody
mixture in samples with varying proportion of RBCs.
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example, in order to decrease the sample volume required for
blood typing, the sample height is often reduced by the use of a
cover glass or a microchannel. In that case, it should be noted that
the proportion of RBCs in the sample that would be required to
cover the entire chip would increase because of the decreased sam-
ple volume per unit area.3.4. Comparison with conventional methods and measurement time
considerations
Our method of hemagglutination detection provides a simple
way of optical-sensor-based blood typing using a portable instru-
ment. The method is as simple as that for manual testing by the
glass slide method, with potentially superior sensitivity. Compared
with the conventional SPR-based blood typing methods [1,5–7]
that require surface modiﬁcations to capture RBCs on the sensor
chips, our method requires no such surface modiﬁcation. This
reduces the sensor chip preparation time. In addition, our method
allows repeat-use of the sensor chips by simply washing trace of
blood and is, therefore, cost-effective. The microchannel-based
blood typing methods [9–11] have reported much smaller amount
of blood sample consumption (generally below 1 lL) than our
method. By introducing microchannels in the sensor system, our
method could also decrease the amount of sample required. The
paper-based blood typing methods [12,13] are considered to be
most easy-to-use and cost-effective, albeit at the cost of accuracy.
We consider our method lies between the paper-based method
and the fully automated blood testing instruments in terms of
the device size and cost, whereas the accuracy can be comparable
with the automated instruments.
The current procedure to obtain bottom reﬂectance differences
shown in Fig. 4(b) took 15 min, which is not considered ideal for
on-site blood testing. One way to shorten the measurement time
is to include multiple-channel optical system into the wave-
guide-mode sensor device. If we used a three-channel wave-
guide-mode sensor, the spectra required for ABO blood typing
(plain blood, blood and anti-A mixture, and blood anti-B mixture)
can be obtained simultaneously. This would reduce the time to
5 min for ABO blood typing, as per the time course spectra shown
in Fig. 3, since the spectral responses approach a plateau within
this timeframe. Further reduction could be achieved by exploiting
the velocity of gravitational sedimentation of RBCs. For example,
RBC sedimentation can be enhanced by applying an electric ﬁeld
[17]. Introducing such systems to the sensor will dramatically
reduce the time required for blood typing using our approach.4. Conclusion
Here, we have described a novel method for hemagglutination
detection for on-site blood testing that is based on a waveguide-
mode sensor. The difference of the bottom reﬂectance between
dips of spectra of agglutinated and non-agglutinated blood sam-
ples was derived from calculations based on the transfer matrix
method, and which account for a change in the contact area ratio
of RBCs at the sensor chip surface. This difference in bottom reﬂec-
tance was also obtained experimentally using diluted human
whole blood and the waveguide-mode sensor. The agglutinated
samples elicited changes between 10% and 35% in the bottom
reﬂectance, while the non-agglutinated samples induced a maxi-
mum change of 7.5%. Blood types A, B, O, and AB can be clearly dis-
tinguished by measuring the bottom reﬂectance difference caused
by addition of anti-A and anti-B reagents to the samples. Although
the agglutination reaction is sometimes difﬁcult to visually discern,
our method did not encounter such issues. In addition, it wasdemonstrated that our method is applicable to not only ABO
forward typing but also Rh(D) typing. Thus, the waveguide-mode
sensor-based blood typing is a promising candidate for on-site
blood testing. Here, we have presented the prototypic version of
the system. By employing advanced optical conﬁgurations and
ﬂuidic systems in the sensor, we hypothesize improvements such
as multiple channel waveguide-mode sensors integrating micro-
channels, which would save time and reduce the volume of sample
required. Furthermore, the system provides the added beneﬁts of
automation and increased sensitivity.
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